MicroPort is a global
medical device
A medical device is any device intended to be used for medical purposes. Significant potential for hazards are inherent when using a device for medical purposes and thus medical devices must be proved safe and effective with reasonable assur ...
developer and manufacturer that is headquartered in
Shanghai, China. It designs and produces products for a range of medical fields including
cardiology
Cardiology () is a branch of medicine that deals with disorders of the heart and the cardiovascular system. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular he ...
,
interventional radiology,
orthopedics
Orthopedic surgery or orthopedics ( alternatively spelt orthopaedics), is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and nonsurgical means to treat musculoskeletal ...
,
electrophysiology, and
surgical management. MicroPort is considered to be among the top 100 medical device companies in 2018 and was selected to be the 2017 China Innovative Medical Device Company.
History
MicroPort was founded in 1998 by Zhaohua Chang, who currently serves as CEO, chairman, and Director. The company rose to prominence from the early success of its
coronary stent line due its focus on serving the needs of the Chinese device market. It is now one of the top global manufacturers of cardiac interventional devices. Notably, it produces the world's first and only commercially available targeted
drug eluting stent system, which uses a significantly reduced amount of drug than traditional drug eluting stents while maintaining effectiveness. As of early 2018, MicroPort is one of few medical device companies still developing a commercial coronary
bioresorbable stent
In medicine, a stent is any device which is inserted into a blood vessel or other internal duct to expand it to prevent or alleviate a blockage. Traditionally, such devices are fabricated from metal mesh and remain in the body permanently or un ...
with ongoing clinical trials.
Beginning in the 2010s, MicroPort has rapidly expanded around the world via international acquisitions to other medical device industries, including orthopedics and cardiac rhythm management, and is valued at over
US$1 Billion.
In 2019, MicroPort announced a
US$398 Million investment to develop pacemakers and defibrillators in
France
France (), officially the French Republic ( ), is a country primarily located in Western Europe. It also comprises of overseas regions and territories in the Americas and the Atlantic, Pacific and Indian Oceans. Its metropolitan ar ...
.
Acquisitions
In 2014 MicroPort expanded operations in the
United States
The United States of America (U.S.A. or USA), commonly known as the United States (U.S. or US) or America, is a country primarily located in North America. It consists of 50 U.S. state, states, a Washington, D.C., federal district, five ma ...
by acquiring Wright Medical's OrthoRecon business to become the 6th largest international producer of orthopedic devices. MicroPort's orthopedic business is based in
Arlington, Tennessee and in 2018 has expanded its business into
India
India, officially the Republic of India ( Hindi: ), is a country in South Asia. It is the seventh-largest country by area, the second-most populous country, and the most populous democracy in the world. Bounded by the Indian Ocean on the ...
.
In 2018 MicroPort and
LivaNova closed the sale of LivaNova's cardiac rhythm management business for $190M.
In 2018 MicroPort purchased Lombard Medical, a US-based endovascular device company, from bankruptcy after it defaulted on loans in early 2018.
References
{{reflist
Medical device manufacturers
Life sciences industry
Medical technology companies of China
Companies listed on the Hong Kong Stock Exchange
Health care companies established in 1998
Technology companies established in 1998
Chinese companies established in 1998
Manufacturing companies based in Shanghai
Chinese brands